Nanotechnology Now - Press Release: Computer-designed vaccine elicits potent antibodies against RSV: The nanoparticle platform for this respiratory syncytial virus study will be applied to vaccine research on flu, HIV, and more; Seattle startup Icosavax will advance related clinical trials
| Date | 9th, Mar 2019 |
|---|---|
| Source | Nanotechnology Now - Nanotechnology Websites |
DESCRIPTION
A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus has been designed in an international research effort. RSV is second only to malaria as a cause of infant mortality w...